Unlock stock picks and a broker-level newsfeed that powers Wall Street.
3 Growth Stocks with Explosive Upside

In This Article:

PINS Cover Image
3 Growth Stocks with Explosive Upside

Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID cycle.

The risks that can come from buying these assets is precisely why we started StockStory - to isolate the long-term winners from the losers so you can invest with confidence. That said, here are three growth stocks where the best is yet to come.

Pinterest (PINS)

One-Year Revenue Growth: +19.3%

Created with the idea of virtually replacing paper catalogues, Pinterest (NYSE: PINS) is an online image and social discovery platform.

Why Does PINS Stand Out?

  1. Has the opportunity to boost monetization through new features and premium offerings as its monthly active users have grown by 10% annually over the last two years

  2. Disciplined cost controls and effective management resulted in a strong two-year EBITDA margin of 26%

  3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends

At $32.50 per share, Pinterest trades at 17.9x forward EV-to-EBITDA. Is now the time to initiate a position? Find out in our full research report, it’s free.

agilon health (AGL)

One-Year Revenue Growth: +40.4%

Founded in 2016, Agilon Health (NYSE:AGL) is a healthcare services company that partners with primary care physicians to enhance patient care and improve health outcomes with a focus on seniors and older individuals.

Why Are We Fans of AGL?

  1. Annual revenue growth of 51.7% over the last two years was superb and indicates its market share increased during this cycle

  2. Customer growth averaged 41.2% over the past two years, showing its ability to "land" new contracts and potentially "expand" them later - a powerful one-two punch for sales

  3. Cash burn has decreased over the last five years, showing the company is becoming a more self-sustaining business

agilon health is trading at $3.89 per share, or 0.3x forward price-to-sales. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.

Amphenol (APH)

One-Year Revenue Growth: +21.3%

With over 90 years of connecting the world's technologies, Amphenol (NYSE:APH) designs and manufactures electrical connectors, sensors, and interconnect systems used in everything from smartphones to aircraft to industrial equipment.

Why Are We Bullish on APH?

  1. Annual revenue growth of 13.1% over the past five years was outstanding, reflecting market share gains this cycle

  2. Enormous revenue base of $15.22 billion provides significant distribution advantages

  3. Earnings growth has massively outpaced its peers over the last five years as its EPS has compounded at 15.1% annually